High Court allows the Wockhardt to sell drug 'Ace ProxyVone', know benefits of this tablet

Rajasthan Tourism App - Welcomes to the land of Sun, Sand and adventures

Internet Desk| The Delhi High Court has barred the restrictions imposed by the Center on the anti-inflammatory drug 'Ace ProxyVone' of Indian drug company Wockhardt on Monday. This drug is used to relieve pain in bone and muscle.

Justice Vishu Bhakru issued this order on the petition of a pharmaceutical company. The drug company had challenged the Central Government's notification on September 7, 2018, in which 328 drugs have been banned, manufacture, sale and distribution. This is the first petition filed against the Ministry of Housing, which has been decided by the court. Many issues are pending before the court. Many other major drug companies including Glenmark, Alkem ​​Laboratories, Observer Biotech, Coral Laboratories, Lupine, Mankind Pharma, Koe Pharmaceuticals, MacLeods and Laboratories have also reached High Court against banning various drugs.

These medicines are used in the liberation of bacterial infections.

These medicines can be used to get rid of pain and get rid of bacterial infection. They also contain antibiotics. The court had reserved its order on November 15 last year on the writ petition of Wockhardt. The company filed a petition in September.

Rajasthan Tourism App - Welcomes to the land of Sun, Sand and adventures


Please enter your comment!
Please enter your name here